Analysts Set Expectations for Henry Schein FY2025 Earnings

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at William Blair boosted their FY2025 EPS estimates for shares of Henry Schein in a research note issued on Wednesday, November 5th. William Blair analyst B. Vazquez now anticipates that the company will post earnings per share of $4.91 for the year, up from their prior estimate of $4.86. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. William Blair also issued estimates for Henry Schein’s Q4 2025 earnings at $1.29 EPS, Q1 2026 earnings at $1.28 EPS and FY2026 earnings at $5.25 EPS.

HSIC has been the topic of a number of other reports. Wall Street Zen cut Henry Schein from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Wells Fargo & Company lifted their price objective on shares of Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a research report on Wednesday. Barrington Research set a $79.00 target price on shares of Henry Schein and gave the stock an “outperform” rating in a research report on Wednesday. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 6th. Finally, JPMorgan Chase & Co. boosted their price objective on Henry Schein from $76.00 to $78.00 and gave the stock an “overweight” rating in a research report on Wednesday. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Henry Schein presently has an average rating of “Hold” and an average price target of $76.08.

Henry Schein Stock Down 2.7%

NASDAQ:HSIC opened at $70.06 on Friday. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The stock has a 50 day moving average of $66.25 and a 200-day moving average of $68.65. The firm has a market capitalization of $8.50 billion, a PE ratio of 22.60, a price-to-earnings-growth ratio of 2.06 and a beta of 0.84. Henry Schein has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.38 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. The business had revenue of $3.34 billion during the quarter, compared to the consensus estimate of $3.28 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS.

Hedge Funds Weigh In On Henry Schein

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. CYBER HORNET ETFs LLC bought a new stake in shares of Henry Schein in the 2nd quarter worth $25,000. MUFG Securities EMEA plc bought a new position in shares of Henry Schein during the 2nd quarter valued at about $27,000. ANTIPODES PARTNERS Ltd acquired a new position in shares of Henry Schein in the 2nd quarter worth approximately $43,000. Steph & Co. bought a new stake in shares of Henry Schein in the 2nd quarter worth approximately $44,000. Finally, CX Institutional lifted its stake in Henry Schein by 107.3% during the second quarter. CX Institutional now owns 651 shares of the company’s stock valued at $48,000 after purchasing an additional 337 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.